Compare Circle Internet Group Inc. Class A Common Stock (CRCL) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Circle Internet Group Inc. Class A Common Stock vs Immunovant Inc. Common Stock — how do they compare? Circle Internet Group Inc. Class A Common Stock trades at $84.95 (market cap $20.52B), while Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B). The key difference: Circle Internet Group Inc. Class A Common Stock is far larger — about 3.3× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Circle Internet Group Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Circle Internet Group Inc. Class A Common Stock for 0 Days and Immunovant Inc. Common Stock for 1 Days on average.
| CRCL | IMVT | |
|---|---|---|
Market Cap | $20.52B | $6.25B |
Volume | 9,813,610 | 1,755,411 |
Sector | Financials | Health |
52-Week High | $150.48 | $44.96 |
52-Week Low | $50.23 | $17.03 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $19.03B | $5.35B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Circle Internet Group Inc. Class A Common Stock
Circle Internet Group provides internet financial infrastructure centered on its stablecoin network. Its business includes stablecoins, blockchain infrastructure for developers, digital-asset services, and payment applications.
Read more on CRCL →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
